{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:11:37Z","timestamp":1769598697555,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T00:00:00Z","timestamp":1471046400000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ijrobp.2015.05.014","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T21:47:16Z","timestamp":1431640036000},"page":"141-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in\u00a0Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study"],"prefix":"10.1016","volume":"93","clinical-trial-number":[{"clinical-trial-number":"nct00534196","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2011-3016","authenticated-orcid":false,"given":"Toshio","family":"Ohashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsunori","family":"Yorozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobumichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihisa","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Maruo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takushi","family":"Dokiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ijrobp.2015.05.014_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2011.10827.x","article-title":"Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group","volume":"109","author":"Grimm","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib2","doi-asserted-by":"crossref","first-page":"38.e1","DOI":"10.1016\/j.urolonc.2013.03.004","article-title":"Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-year experience at Mount Sinai Medical Center","volume":"32","author":"Marshall","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib3","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/cncr.27911","article-title":"Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer","volume":"119","author":"Morris","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2010.05.042","article-title":"Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience","volume":"81","author":"Sylvester","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ijrobp.2010.04.038","article-title":"10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: Results for 1,100 patients","volume":"80","author":"Crook","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2006.08.056","article-title":"Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation","volume":"67","author":"Zelefsky","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.juro.2011.09.045","article-title":"Factors influencing urinary symptoms 10 years after permanent prostate seed implantation","volume":"187","author":"Stone","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijrobp.2008.05.022","article-title":"Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: Long-term outcome in 712 consecutive patients","volume":"73","author":"Keyes","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.juro.2007.08.136","article-title":"Long-term urinary sequelae following 125iodine prostate brachytherapy","volume":"179","author":"Crook","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib10","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.urology.2010.07.539","article-title":"Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer","volume":"77","author":"Zelefsky","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0360-3016(01)01442-0","article-title":"Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis","volume":"50","author":"Snyder","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib12","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.ijrobp.2011.01.012","article-title":"Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: Rectal dose-volume histogram analysis of 457 patients","volume":"81","author":"Shiraishi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib13","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ijrobp.2013.04.033","article-title":"Predictive factors and management of rectal bleeding side effects following prostate cancer brachytherapy","volume":"86","author":"Price","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2010.05.056","article-title":"Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the\u00a0prostate (RTOG 98-05)","volume":"81","author":"Lawton","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib15","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1016\/j.ijrobp.2011.11.040","article-title":"Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate","volume":"82","author":"Lawton","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10147-014-0704-4","article-title":"Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS)","volume":"20","author":"Saito","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0360-3016(99)00069-3","article-title":"American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer","volume":"44","author":"Nag","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib18","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1002\/cncr.26203","article-title":"Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: Long-term results of CALGB 99809","volume":"117","author":"Hurwitz","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijrobp.2006.08.030","article-title":"Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer","volume":"67","author":"Zelefsky","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.radonc.2004.08.003","article-title":"Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy","volume":"73","author":"Wust","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2007.12.002","article-title":"Combined brachytherapy with external beam radiotherapy for localized prostate cancer: Reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy","volume":"7","author":"Zelefsky","year":"2008","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijrobp.2014.06.037","article-title":"Late urinary side effects 10 years after low-dose-rate prostate brachytherapy: Population-based results from a multiphysician practice treating with a standardized protocol and uniform dosimetric goals","volume":"90","author":"Keyes","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib23","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","article-title":"Symptomatic toxicities experienced during anticancer treatment: Agreement between patient and physician reporting in three randomized trials","volume":"33","author":"Di Maio","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2004.07.026","article-title":"Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy","volume":"73","author":"Williams","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0360-3016(00)00632-5","article-title":"Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer","volume":"48","author":"Gelblum","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib26","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0360-3016(02)04527-3","article-title":"The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: Morbidity outcomes from two prospective randomized multicenter trials","volume":"55","author":"Ghaly","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jjco\/hyl133","article-title":"Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry","volume":"37","author":"Ohashi","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib28","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/cncr.11595","article-title":"Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy","volume":"98","author":"Albert","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib29","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/cncr.20446","article-title":"Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy","volume":"101","author":"Sarosdy","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0360-3016(01)02811-5","article-title":"Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy","volume":"53","author":"Kang","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib31","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ijrobp.2008.01.010","article-title":"Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: An initial report of CALGB 99809","volume":"72","author":"Hurwitz","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib32","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/cncr.22560","article-title":"Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: Analysis of Radiation Therapy Oncology Group study 0019","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.brachy.2009.08.012","article-title":"Late rectal toxicity after prostate brachytherapy: Influence of supplemental external beam radiation on dose-volume histogram analysis","volume":"9","author":"Kalakota","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2015.05.014_bib34","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ijrobp.2005.09.002","article-title":"A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: Preliminary results of RTOG P-0019","volume":"64","author":"Lee","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615005180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615005180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:41:38Z","timestamp":1759743698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301615005180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0360301615005180"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.05.014","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in\u00a0Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}